Business
Spectral announces shareholder approval for sale of rapid cardiac test business
Spectral announces shareholder approval for sale of rapid cardiac test business.
About this update from Spectral Medical Inc
[{"type":"text","content":"\n\n\n\n\nTORONTO, Jan. 20 /CNW/ - Spectral Diagnostics Inc. (TSX: SDI) announced\nthat at its special meeting of shareholders held earlier today, shareholders\noverwhelmingly approved the previously announced sale of Spectral's rapid\ncardiac immunoassay test business to Nanogen, Inc., voting 99.9% in favour.\n\nThe transaction is expected to close in due course and remains subject to\nother customary closing conditions.\n\nAbout Spectral Diagnostics, Inc.\n--------------------------------\n\nSpectral is a developer of innovative technologies for comprehensive\ndisease management. Spectral provides accurate and timely information to\nclinicians enabling the early initiation of appropriate and targeted therapy.\nSpectral's common shares are listed on The Toronto Stock Exchange: SDI. For\nadditional information please visit Spectral's website at www.spectraldx.com.\n\nInformation in this news release that is not current or historical\nfactual information may constitute forward-looking information within the\nmeaning of securities laws. Implicit in this information, the future outlook\nof Spectral and anticipated events or results, are assumptions based on\nbeliefs of Spectral's senior management as well as information currently\navailable to it. While these assumptions were considered reasonable by\nSpectral at the time of preparation, they may prove to be incorrect. Readers\nare cautioned that actual results are subject to a number of risks and\nuncertainties, including the availability of funds and resources to pursue R&D\nprojects, the successful and timely completion of clinical studies, the\nability of Spectral to take advantage of business opportunities in the\nbiomedical industry, the granting of necessary approvals by regulatory\nauthorities as well as general economic, market and business conditions, and\ncould differ materially from what is currently expected.\n%SEDAR: 00002006E\n\n\n","length":1967,"tagName":"div"}]